HNO International (HNOI) Common Equity (2022 - 2026)

HNO International has disclosed Common Equity across 5 years of filings, most recently posting -$1.7 million for Q1 2026.

• Quarterly Common Equity rose 3.09% year-over-year to -$1.7 million in Q1 2026, while the trailing twelve-month figure through Jan 2026 was -$1.7 million (up 3.09% YoY) and the FY2025 annual result came in at -$1.6 million, down 16.64% from the prior year.
• Common Equity declined to -$1.7 million in Q1 2026, from -$1.6 million in the prior quarter.
• Over five years, Common Equity peaked at $296105.0 in Q3 2023 and troughed at -$1.8 million in Q1 2025.
• A 5-year average of -$1.1 million and a median of -$1.1 million in 2022 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2023 — Common Equity soared 135.59% — and 2024, when it slumped 623.72%.
• Tracing HNOI's Common Equity over 5 years: stood at -$1.1 million in 2022, then soared by 82.61% to -$193085.0 in 2023, then sank by 623.72% to -$1.4 million in 2024, then fell by 16.64% to -$1.6 million in 2025, then retreated by 4.12% to -$1.7 million in 2026.
• Business Quant data shows HNOI's Common Equity at -$1.7 million in Q1 2026, -$1.6 million in Q4 2025, and -$1.6 million in Q3 2025.